Reviva Pharmaceuticals -CW23RVPHWPreferred / convertible
13F holders, Q1 2025 (March 31)1holders −1
1new positions
2sold out
$0.06avg. 13F price*
At the end of Q1 2025, 1 institutions reported holding Reviva Pharmaceuticals -CW23 (RVPHW) in their 13F filings, down 1 from Q4 2024. 1 opened new positions and 2 sold out. The largest holder was Virtu Financial LLC ($1K).
- Company
- Reviva Pharmaceuticals -CW23
- CUSIP
- 76152G118
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $1K |
| Exits | 2 | $628 |
All 13F filers, Q4 2024 → Q1 2025: 16,100 shares bought and 3,834 shares sold, net +12,266 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Virtu Financial LLC | — | New | 16,100 | $1K |
"% of holder's portfolio" is RVPHW's weight in each manager's 13F, not the share of Reviva Pharmaceuticals -CW23 the manager owns.